NCBI Summary
Angiopoietins are proteins with important roles in vascular development and angiogenesis. All angiopoietins bind with similar affinity to an endothelial cell-specific tyrosine-protein kinase receptor. The mechanism by which they contribute to angiogenesis is thought to involve regulation of endothelial cell interactions with supporting perivascular cells. The protein encoded by this gene functions as an agonist and is an angiopoietin. [provided by RefSeq, Jul 2008].
Protein
Protein (NP_057069)
Angiopoietin-4
Angiopoietin-4 (ANG-4) (Angiopoietin-3) (ANG-3)
ANGPT4
angiopoietin 4
Undefined
Very low evidence
Ficolin-like
Undefined
a/b mixed with b-sheet / Fibrinogen C-ter like
MLSQLAMLQGSLLLVVATMSVAQQTRQEADRGCETLVVQHGHCSYTFLLPKSEPCPPGPEVSRDSNTLQRESLANPLHLGKLPTQQVKQLEQALQNNTQWLKKLERAIKTILRSKLEQVQQQMAQNQTAPMLELGTSLLNQTTAQIRKLTDMEAQLLNQTSRMDAQMPETFLSTNKLENQLLLQRQKLQQLQGQNSALEKRLQALETKQQEELASILSKKAKLLNTLSRQSAALTNIERGLRGVRHNSSLLQDQQHSLRQLLVLLRHLVQERANASAPAFIMAGEQVFQDCAEIQRSGASASGVYTIQVSNATKPRKVFCDLQSSGGRWTLIQRRENGTVNFQRNWKDYKQGFGDPAGEHWLGNEVVHQLTRRAAYSLRVELQDWEGHEAYAQYEHFHLGSENQLYRLSVVGYSGSAGRQSSLVLQNTSFSTLDSDNDHCLCKCAQVMSGGWWFDACGLSNLNGVYYHAPDNKYKMDGIRWHYFKGPSYSLRASRMMIRPLDI
No structure currently available in the PDB RCSB Databank.
Structural models
SWISS-MODEL structural models
The location of the lectin domain structural model is: 282-502
We infer [1.37, 1.69] Å as the interval of error of this structural model.
Template 1: 6ZQX chain: A, Q8N539, NP_116232.3, sequence identity: 41.6%, coverage: 96.8%, location in sequence: 239-457, (239-457 in PDB).
Template 2: 2JHK chain: F, O00602, NP_001994.2, sequence identity: 38.5%, coverage: 98.2%, location in sequence: 110-326, (81-297 in PDB).
Template 3: 2J3U chain: B, Q15485, NP_004099.2, sequence identity: 37.6%, coverage: 97.3%, location in sequence: 96-313, (71-288 in PDB).
Show the alignment used for the construction of the structural model, Download.
Show the plot of DOPE energy score, Download.
We infer [1.37, 1.69] Å as the interval of error of this structural model.
Template 1: 6ZQX chain: A, Q8N539, NP_116232.3, sequence identity: 41.6%, coverage: 96.8%, location in sequence: 239-457, (239-457 in PDB).
Template 2: 2JHK chain: F, O00602, NP_001994.2, sequence identity: 38.5%, coverage: 98.2%, location in sequence: 110-326, (81-297 in PDB).
Template 3: 2J3U chain: B, Q15485, NP_004099.2, sequence identity: 37.6%, coverage: 97.3%, location in sequence: 96-313, (71-288 in PDB).
Show the alignment used for the construction of the structural model, Download.
Show the plot of DOPE energy score, Download.
Ligand
Glycan ligands from structural data
No crystal structures of complexes with glycan ligand.
References
NCBI References (10 PubMed Identifiers)
- Dual functional nanoparticles containing SOX duo and ANGPT4 shRNA for osteoarthritis treatment. [30957437]
- Angiopoietin-4 increases permeability of blood vessels and promotes lymphatic dilation. [25977256]
- Acute-phase protein alpha1-antitrypsin--a novel regulator of angiopoietin-like protein 4 transcription and secretion. [24760148]
- Angiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes. [22267746]
- Prognostic impacts of angiopoietins in NSCLC tumor cells and stroma: VEGF-A impact is strongly associated with Ang-2. [21603628]
- The DNA sequence and comparative analysis of human chromosome 20. [11780052]
- Angiopoietin-3, a novel member of the angiopoietin family. [10218486]
- Angiopoietins 3 and 4: diverging gene counterparts in mice and humans. [10051567]
- Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. [10025962]
- Assignment of ANGPT4, ANGPT1, and ANGPT2 encoding angiopoietins 4, 1 and 2 to human chromosome bands 20p13, 8q22.3-->q23 and 8p23.1, respectively, by in situ hybridization and radiation hybrid mapping. [10343124]
UniProt Main References (4 PubMed Identifiers)
- Complete sequencing and characterization of 21,243 full-length human cDNAs. [14702039]
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). [15489334]
- Biological characterization of angiopoietin-3 and angiopoietin-4. [15284220]
- Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. [19234476]
All isoforms of this gene containing a lectin domain
RNA
RNA (Transcript ID: NM_015985.4)
m7G-5')ppp(5'-AGACAGAGGUUUGUAGCUGCAGCUGCAGGCAAGCCUGGCCACUGUUGGCUGCAGCAGGACAUCCCAGGCACAGCCCCUAGGGCUCUGAGCAGACAUCCCUCGCCAUUGACACAUCUUCAGAUGCUCUCCCAGCUAGCCAUGCUGCAGGGCAGCCUCCUCCUUGUGGUUGCCACCAUGUCUGUGGCUCAACAGACAAGGCAGGAGGCGGAUAGGGGCUGCGAGACACUUGUAGUCCAGCACGGCCACUGUAGCUACACCUUCUUGCUGCCCAAGUCUGAGCCCUGCCCUCCGGGGCCUGAGGUCUCCAGGGACUCCAACACCCUCCAGAGAGAAUCACUGGCCAACCCACUGCACCUGGGGAAGUUGCCCACCCAGCAGGUGAAACAGCUGGAGCAGGCACUGCAGAACAACACGCAGUGGCUGAAGAAGCUAGAGAGGGCCAUCAAGACGAUCUUGAGGUCGAAGCUGGAGCAGGUCCAGCAGCAAAUGGCCCAGAAUCAGACGGCCCCCAUGCUAGAGCUGGGCACCAGCCUCCUGAACCAGACCACUGCCCAGAUCCGCAAGCUGACCGACAUGGAGGCUCAGCUCCUGAACCAGACAUCAAGAAUGGAUGCCCAGAUGCCAGAGACCUUUCUGUCCACCAACAAGCUGGAGAACCAGCUGCUGCUACAGAGGCAGAAGCUCCAGCAGCUUCAGGGCCAAAACAGCGCGCUCGAGAAGCGGUUGCAGGCCCUGGAGACCAAGCAGCAGGAGGAGCUGGCCAGCAUCCUCAGCAAGAAGGCGAAGCUGCUGAACACGCUGAGCCGCCAGAGCGCCGCCCUCACCAACAUCGAGCGCGGCCUGCGCGGUGUCAGGCACAACUCCAGCCUCCUGCAGGACCAGCAGCACAGCCUGCGCCAGCUGCUGGUGUUGUUGCGGCACCUGGUGCAAGAAAGGGCUAACGCCUCGGCCCCGGCCUUCAUAAUGGCAGGUGAGCAGGUGUUCCAGGACUGUGCAGAGAUCCAGCGCUCUGGGGCCAGUGCCAGUGGUGUCUACACCAUCCAGGUGUCCAAUGCAACGAAGCCCAGGAAGGUGUUCUGUGACCUGCAGAGCAGUGGAGGCAGGUGGACCCUCAUCCAGCGCCGUGAGAAUGGCACCGUGAAUUUUCAGCGGAACUGGAAGGAUUACAAACAGGGCUUCGGAGACCCAGCUGGGGAGCACUGGCUGGGCAAUGAAGUGGUGCACCAGCUCACCAGAAGGGCAGCCUACUCUCUGCGUGUGGAGCUGCAAGACUGGGAAGGCCACGAGGCCUAUGCCCAGUACGAACAUUUCCACCUGGGCAGUGAGAACCAGCUAUACAGGCUUUCUGUGGUCGGGUACAGCGGCUCAGCAGGGCGCCAGAGCAGCCUGGUCCUGCAGAACACCAGCUUUAGCACCCUUGACUCAGACAACGACCACUGUCUCUGCAAGUGUGCCCAAGUGAUGUCUGGAGGGUGGUGGUUUGACGCCUGUGGCCUGUCAAACCUCAACGGCGUCUACUACCACGCUCCCGACAACAAGUACAAGAUGGACGGCAUCCGCUGGCACUACUUCAAGGGCCCCAGCUACUCACUGCGUGCCUCUCGCAUGAUGAUACGGCCUUUGGACAUCUAACGAGCAGCUGUGCCAGAGGCUGGACCACACAGGAGAAGCUCGGACUUGGCACUCCUGGACAACCUGGACCCAGAUGCAAGACACUGUGCCACCGCCUUCCCUGACACCCUGGGCUUCCUGAGCCAGCCCUCCUUGACCCAGAAGUCCAGAAGGGUCAUCUGCCCCCCAACUCCCCUCCGUCUGUGACAUGGAGGGUGUUCGGGGCCCAUCCCUCUGAUGUAGUCCUCGCCCCUCUUCUCUCCCUCCCCCUUCAGGGGCUCCCUGCCUGAGGGUCACAGUACCUUGAAUGGGCUGAGAACAGACCAAACUUGAUUCCCAUGACCAAUGGUGGGGUUGCAGGCAGGUGGGAAUGUAUUUGCACAUCGGAAGCUGCCCAGAUGGCCCAGGUUCUCUCCCUUGGAUUGGCAAGAAGGCCAUCUCCCAUUCUAAGCUCCUGUUCCAAGAUUUUCUAGUCUUGAGAUGUCCUUGAACUUUCUUUUCAAGUCUGAAGGGGCUGCAUCCACCCCUUAGUGGGUGGGUUAAUCAUUAUUUCCCCUUCACACUUCACCACUUCUAGGUUCUAAUGACCCUAGAUCUCAGGGUCUUUAGACUUCACCACUUCUAGGCUUUACCACUUCACCACUUCUAGGCUCCAAUGUUUGGAGCUCAGGGUCUUUAGGAGACCCAAAAGGACAUGCUCCUUCACCUCCAGCAUGUCCUAGAGGAUGUGUCACAGGGAAUAACUAUGGCUUGUCUCUAAAAGUACCUAUGAGCAAUGAGAAAAGGAAACAGCAGGUUAAGUCAAAGUGAACAGGCACUCUUCACUGCAGGACUGAUCAGAGCCUUUAAUAUGGCCAAGUGCCUUGUGACUACCCAUGAAGGGGCUAGAGUGGGCAGCUUUCUCCAAAUUUACUUAUUUGAAAAUGGGCUCGGUUUGUCCCAGAGCAUCUCACAGGACUGUAGAUGCUCUUGGACAAAGCUAGUGCUCCCCUGGCAUAAGGAGGAGCCCUACGACCCCAUCCCCACCCCAGCUAUACUCACCCUUUUUGGCUACAAGGGCCACAGUGACAGCCUCAAACAACCUCUAAAAACAACUGGAAAUAACCUUUCAGUUAAAACAGAUACCAUCCCUGAAGAAGGGUCUAGAACUAGGUCCCUGUCUGUGUUAUAGGCUCAUGUCCUCCAAGGCUCCUUCAAGUCCCAGGAAGCUGAUCUCUACCUGGGUGGCUUCCCUUAGGACUCCCUGUAACCUCAACUCCCCCAGGCUCAAUUACAGGGACUGUUAGGCAGGACAUCUGUCUCCAAGUCCAGAUCCUCUCUGCCUCCAAGCCCUAACCCCUAGCCUCCCUCCCUUCCCCAUCCAGCAGUGAUGCUGCCUCUGUGGUGGUAGGUGGGGAGCUGCAGGGGAGGAGAUAAGGCCUCUGCCUGAGUUUGGGAGACCAGGGCCCUCAUAGCUUCUUUCAGAGGAUGGAGUCAGAAAGGAUCCACAGCUACUCUGUCACCUGCCCCCAUCACUGUGUCAUGCUGUCUGCCCUGUUGUCAUCAGCCAACACCCAGGCAUAGCCAGGAGCCCACCUGCCCUACCGCCAGGAUACACCUCUGUCCUCAGAAGGUUUUCUCCUGGAUGAGACUGAGCCAAUGGGAAUGGGACCCCUUCAUCCCCCUGGCUCGCCCCAGCCCUGAGUCCCACUCUCAGCCGAUCCCUGAGUAAACCCAGCACAGACUGACUUUGAUCUCAUUCCUGGGAAUUAGCACUCUUCCCCUUCAAGACUCAAAGGACAUGGUUGCUAAUGGUGGCAUUUCAGGCAUGAUGGGAAAUCUUUAGGGGCAGAUUGCUGCCCAGAGAGCUCAAAUCGCCUUAAGCAGCAUUUGCCCAGCAGACCUUUAUUUAGCCUCUACUGUGUGCAGUGUGGUGUGGUGGGCAGGGCUUUGGAGUCGGACAAACCUGCUCCAGCUCUGACACUUUGGUCCAGUGGCUCAGCCUCUCAAGGCACCAGUUAUCUUCACAUCAUCAAAGCCUCAGUUUUCCCAUCUGUAAAAUGGAGAUGAUAAUAUUCCUUCCUGGCUGGGCUAUGGCAAGGAGGAAAUGAGACCAUGUAUGUCAUCUUCUUAAUAGAGCCUGGCAUGAAGCAGGUGCCUAAUAAAUGUUUGUCCUCAAAGAGGAGAAUGGGGUGAGGAAGGCAUUCCCCAGCACAUGCCGCCCCUUCUCCUGCACUCAGGUGAGGAAAAGGCAUUUUAUUUUUGUAUCCACAUCAUUUAUUUUUCUAUUGUAGUUUCUAGGCUGACUGCAAGCUAGAGAGGAGACAGGGCAAAGCUGUGAGGCCCAGGGACAGAACUCCUCUGGGUGGGUUGAAGGCCCAAGUCCCUCUCUACUCCCAUUUUAUAAGGGGGCAGGAAGCUGAUUUGAGUUAUCCUCAGACACCUGUUCUUUAUGUAAUUUUAUUUUAUUUUUUUGAGACAGAGUCUCACUCUGUCACCCAGGCUGGAGUGCAGUGGCAUGAUCUCAGAUCACUGCAAUCUCUGCCUCCUGGUUCAAGUGAUUCUCCUACCUCAGCCUCCUGAGUAAUGGGAUUACAGACGCCUACCACCACGCCCGGAAAACUUUUGUAUUUUUAGUAGAAACGGGUUUUCACCAUGUUGGCCAGGCUGGUCUCAAACUCCUGGCCUCAUGUGAUCCACCUGCCUCAGCCUCCCAAAGUGCUGGGAUUACAGGCAUGAGCCACCAUACCCAGCCUCAGACACCUGUUCUUAAAUAUUCAUCCUUCUUUCUUACCUUCCUUCCUCUUCCAUGCCAGGACUCAGGUAUAAGGGAUAGAAAUUCUAGCCCUAAGGAAUAAAUUGACUCACAUAACUGGAAAGUCUAAGGGUAAAGGCAAGUGAGGUUAGAUCCAGAGGCUCAAAUGAUGUCAGCUCCACCUCUCAGCCCCUCCAUCUGCCCCGUUGACUUCAUUCUCAGCCAGGAUCUUUCCUCACAAGAAGGCUCUGGCAGCCCCAGGCUCAUGUCCUCCCAGCUCAGCAUCCCUGACCCGGGGAGCUCCCUCGUCUCCAUGAUUCCAGUAAAGGAAUGAUUUUCUGCAGCCA-3'- Poly-A tail
- Coding region
DNA
DNA (Gene ID: 51378)
angiopoietin 4
strand -
NCBI CDS gene sequence (1512 bp)
5'-ATGCTCTCCCAGCTAGCCATGCTGCAGGGCAGCCTCCTCCTTGTGGTTGCCACCATGTCTGTGGCTCAACAGACAAGGCAGGAGGCGGATAGGGGCTGCGAGACACTTGTAGTCCAGCACGGCCACTGTAGCTACACCTTCTTGCTGCCCAAGTCTGAGCCCTGCCCTCCGGGGCCTGAGGTCTCCAGGGACTCCAACACCCTCCAGAGAGAATCACTGGCCAACCCACTGCACCTGGGGAAGTTGCCCACCCAGCAGGTGAAACAGCTGGAGCAGGCACTGCAGAACAACACGCAGTGGCTGAAGAAGCTAGAGAGGGCCATCAAGACGATCTTGAGGTCGAAGCTGGAGCAGGTCCAGCAGCAAATGGCCCAGAATCAGACGGCCCCCATGCTAGAGCTGGGCACCAGCCTCCTGAACCAGACCACTGCCCAGATCCGCAAGCTGACCGACATGGAGGCTCAGCTCCTGAACCAGACATCAAGAATGGATGCCCAGATGCCAGAGACCTTTCTGTCCACCAACAAGCTGGAGAACCAGCTGCTGCTACAGAGGCAGAAGCTCCAGCAGCTTCAGGGCCAAAACAGCGCGCTCGAGAAGCGGTTGCAGGCCCTGGAGACCAAGCAGCAGGAGGAGCTGGCCAGCATCCTCAGCAAGAAGGCGAAGCTGCTGAACACGCTGAGCCGCCAGAGCGCCGCCCTCACCAACATCGAGCGCGGCCTGCGCGGTGTCAGGCACAACTCCAGCCTCCTGCAGGACCAGCAGCACAGCCTGCGCCAGCTGCTGGTGTTGTTGCGGCACCTGGTGCAAGAAAGGGCTAACGCCTCGGCCCCGGCCTTCATAATGGCAGGTGAGCAGGTGTTCCAGGACTGTGCAGAGATCCAGCGCTCTGGGGCCAGTGCCAGTGGTGTCTACACCATCCAGGTGTCCAATGCAACGAAGCCCAGGAAGGTGTTCTGTGACCTGCAGAGCAGTGGAGGCAGGTGGACCCTCATCCAGCGCCGTGAGAATGGCACCGTGAATTTTCAGCGGAACTGGAAGGATTACAAACAGGGCTTCGGAGACCCAGCTGGGGAGCACTGGCTGGGCAATGAAGTGGTGCACCAGCTCACCAGAAGGGCAGCCTACTCTCTGCGTGTGGAGCTGCAAGACTGGGAAGGCCACGAGGCCTATGCCCAGTACGAACATTTCCACCTGGGCAGTGAGAACCAGCTATACAGGCTTTCTGTGGTCGGGTACAGCGGCTCAGCAGGGCGCCAGAGCAGCCTGGTCCTGCAGAACACCAGCTTTAGCACCCTTGACTCAGACAACGACCACTGTCTCTGCAAGTGTGCCCAAGTGATGTCTGGAGGGTGGTGGTTTGACGCCTGTGGCCTGTCAAACCTCAACGGCGTCTACTACCACGCTCCCGACAACAAGTACAAGATGGACGGCATCCGCTGGCACTACTTCAAGGGCCCCAGCTACTCACTGCGTGCCTCTCGCATGATGATACGGCCTTTGGACATCTAA-3'
By using this site you agree to our privacy policy.
Please confirm you agree with the privacy policy before using the site.